AD012 是cACE/NEP的双重抑制剂。AD012 是基于先前报道的 C 域选择性 ACE 抑制剂赖诺普利-色氨酸合成的。AD012 具有提供强效抗高血压和心脏保护作用的潜力。

AD012 is a dual inhibitor of cACE / NEP. AD012 is synthesized based on the previously reported C-domain selective ACE inhibitor lisinopril-tryptophan. AD012 has the potential for providing the potent antihypertensive and cardioprotective benefits [1].

C25H32N2O6

456.53

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years